Sophie Abgrall

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV

Sophie Grabar, Hana Selinger‐Leneman, Sophie Abgrall et al. · AIDS · 2009 · 203 citations

Public Health, Infectious Diseases, Clinical Epidemiology +13

Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients

Suzanne M Ingle, Margaret May, M. John Gill et al. · Clinical Infectious Diseases · 2014 · 152 citations · Full text

Public Health, Health Sciences, Infectious Diseases +15

Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies

Adam Trickey, Kathleen A. McGinnis, M. John Gill et al. · The Lancet HIV · 2024 · 149 citations · Full text

Public Health, Population Health Sciences, Clinical Epidemiology +15

Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples

Sara Lodi, Andrew Phillips, Jens Lundgren et al. · American Journal of Epidemiology · 2019 · 115 citations · Full text

Public Health, Biostatistics, Infectious Diseases +17